Michael Austin Loesche, M.D.,Ph.D.
This page shows the publications Michael Loesche has written about Seroepidemiologic Studies.
SARS-CoV-2 antibodies protect against reinfection for at least 6 months in a multicentre seroepidemiological workplace cohort. PLoS Biol. 2022 02; 20(2):e3001531.
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.